Back
Janux Therapeutics Quote, Financials, Valuation and Earnings
Invest. Do Good. Get Rewarded. Just $0.26/Share!
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
34
JANX
Janux Therapeutics
Last Price:
50.47
Seasonality Move:
7.34%
7 Day Trial
ALL ACCESS PASS
$
7
Trade on Tuesday. Profit on Friday. Rinse & Repeat
Get the full details now.Janux Therapeutics Price Quote
$50.47
+3.97 (+8.54%)
(Updated: November 22, 2024 at 5:55 PM ET)
Janux Therapeutics Key Stats
Sell
34
Janux Therapeutics (JANX)
is a Sell
Day range:
$45.95 - $49.78
52-week range:
$7.79 - $65.60
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
182.49
P/B ratio:
3.72%
Volume:
786K
Avg. volume:
670.2K
1-year change:
434.48%
Market cap:
$2.4B
Revenue:
$8.1M
EPS:
$-1.16
How Much Does Janux Therapeutics Make?
-
How Much Are Janux Therapeutics's Sales Annually?
JANX Revenues are $8.1M -
How Much Profit Does Janux Therapeutics's Make A Year?
JANX net income is -$58.3M
Is Janux Therapeutics Growing As A Company?
-
What Is Janux Therapeutics's Growth Rate Quarterly?
Quarterly YoY revenue growth is -0.83% -
What Is Janux Therapeutics's EPS Quarterly YoY Growth Rate?
Quarterly, year-over-year diluted EPS growth rate is 0%
Janux Therapeutics Stock Price Performance
-
Did Janux Therapeutics Stock Go Up Last Month?
Janux Therapeutics share price went down by -7.9% last month -
Did JANX's Share Price Rise Over The Last Year?
JANX share price rose by 434.48% over the past 1 year
What Is Janux Therapeutics 52-Week High & Low?
-
What Is Janux Therapeutics’s 52-Week High Share Price?
Janux Therapeutics has traded as high as $65.60 over the past 52 weeks -
What Is Janux Therapeutics’s 52-Week Low Share Price?
Janux Therapeutics has traded as low as $7.79 over the past 52 weeks
Janux Therapeutics Price To Free Cash Flow
Data Unavailable
Is It Risky To Buy Janux Therapeutics?
-
How Much Debt Does Janux Therapeutics Have?
Total long term debt quarterly is $0 -
How Much Cash Does Janux Therapeutics Have?
Cash and short term investments quarterly total is $658M -
What Is Janux Therapeutics’s Book Value Per Share?
Book value per share is 12.54
Is Janux Therapeutics Cash Flow Positive?
-
What Is JANX Cash Flow From Operations?
Cash flow from operations (TTM) is -$37M -
What Is Janux Therapeutics’s Cash Flow From Financing?
Cash flow from financing (TTM) is $327.4M -
What Is Janux Therapeutics’s Cash Flow From Investing?
Cash flow from investing (TTM) is -$280.8M
Janux Therapeutics Return On Invested Capital
-
Is Management Doing A Good Job?
JANX return on invested capital is -11.37% -
What Is Janux Therapeutics Return On Assets?
ROA measures how assets are converting to revenues and is -10.65% -
What Is JANX Return On Equity?
ROE is a measure of profitability and is -11.37%
Janux Therapeutics Earnings Date & Stock Price
-
What Is Janux Therapeutics's Stock Price Today?
A single share of JANX can be purchased today for 46.50 -
What Is Janux Therapeutics’s Stock Symbol?
Janux Therapeutics trades on the nasdaq under the ticker symbol: JANX -
When Is Janux Therapeutics’s Next Earnings Date?
The next quarterly earnings date for Janux Therapeutics is scheduled on May 8, 2025 -
When Is JANX's next ex-dividend date?
Janux Therapeutics's next ex-dividend date is November 23, 2024 -
How To Buy Janux Therapeutics Stock?
You can buy Janux Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
Janux Therapeutics Competitors
-
Who Are Janux Therapeutics's Competitors?
Below is a list of companies who compete with Janux Therapeutics or are related in some way:
Janux Therapeutics Dividend Yield
-
What Is JANX Dividend Yield?
Janux Therapeutics’s dividend yield currently is 0% -
What Is Janux Therapeutics’s Payout Ratio?
Janux Therapeutics’s payout ratio is 0% -
When Did Janux Therapeutics Last Pay A Dividend?
The latest dividend pay date is November 23, 2024 -
What Is Janux Therapeutics’s Dividend Per Share?
Janux Therapeutics pays a dividend of $0.00 per share
Janux Therapeutics Analyst Estimates
| YoY Growth | Past Surprise | |
|---|---|---|
| EPS: | 0% | -42.99% |
| Revenue: | -82.56% | -73.32% |
Analyst Recommendations
| Buy Recommendations: | 10 |
|---|---|
| Hold Recommendations: | 1 |
| Sell Recommendations: | 0 |
| Price Target: | 66.18 |
| Upside from Last Price: | 42.33% |